Drug Delivery Devices Market to Grow by USD 77.26 bn | Increasing Life Expectancy to Drive Global Pharmaceuticals Market | Technavio

Find additional information about market landscape, Get a Free PDF Sample Report

Growth in the global pharmaceuticals market will be driven by factors such as increasing life expectancy, rising prevalence of sedentary lifestyle, and increase in cases of chronic conditions.

Drug Delivery Devices Market 2022-2026: Scope

The drug delivery devices market report covers the following areas:

• Drug Delivery Devices Market size
• Drug Delivery Devices Market trends
• Drug Delivery Devices Market industry analysis

Drug Delivery Devices Market 2022-2026: Segmentation

By route of administration, the market has been segmented into oral, injectable, pulmonary, and others. The oral segment will have significant market share growth during the forecast period. The growing prevalence of chronic conditions such as cancer, cardiovascular diseases, diabetes, and infectious diseases is expected to drive the growth of this segment during the forecast period.

By geography, the market is segmented into North America, Europe, Asia, and ROW. North America will have the highest market share growth during the forecast period.

Learn more about the contribution of each segment. Download a Free Sample

Drug Delivery Devices Market 2022-2026: Driver and Challenge

The growing prevalence of chronic conditions is one of the key factors driving the growth of the drug delivery devices market. The prevalence of chronic diseases, such as diabetes, chronic kidney disease, cancer, arthritis, and Alzheimer's disease, is growing worldwide, especially in developed countries such as the US, Canada, the UK, Australia, France, Germany, and others. This can be attributed to the changes in the lifestyle and eating habits of consumers in these countries.

Product recalls will challenge the drug delivery devices market during the forecast period. They can impact a company's sales, brand image, and consumer confidence. This can create pitfalls such as low-volume generation and limited product demand, leading to significant financial losses for vendors.

Drug Delivery Devices Market 2022-2026: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the drug delivery devices market, including 3M Co., AbbVie Inc., Antares Pharma Inc., Becton Dickinson and Co., BIOCORP Production, F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others.

Subscribe to our "Lite Plan" billed annually at USD 3000 that enables you to download 3 reports/year and view 3 reports/month.

Drug Delivery Devices Market 2022-2026: Key Highlights

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will assist drug delivery devices market growth during the next five years
• Estimation of the drug delivery devices market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the drug delivery devices market
• Analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of drug delivery devices market vendors

Related Reports:

Non-small Cell Lung Cancer Drugs Market by Product and Geography - Forecast and Analysis 2022-2026

Botanical and Plant-Derived Drugs Market by Type and Geography - Forecast and Analysis 2022-2026

Table Of Contents :

***1. Executive Summary 

  **1.1 Market Overview

  *Exhibit 01:  Key Finding 1

  *Exhibit 02:  Key Finding 2

  *Exhibit 03:  Key Finding 3

  *Exhibit 04:  Key Finding 5

  *Exhibit 05:  Key Finding 6

  *Exhibit 06:  Key Finding 7

  *Exhibit 07:  Key Finding 8

***2. Market Landscape 

  **2.1 Market ecosystem 

  *Exhibit 08:  Parent market

  *Exhibit 09:  Market characteristics

  **2.2 Value chain analysis 

  *Exhibit 10: Value chain analysis:

  *2.2.1 Research and Development (R&D)– Drug discovery

  *2.2.2 Integration and product development

  *2.2.3 Manufacturing

  *2.2.4 Outbound logistics:

  *2.2.5 Marketing and sales:

  *2.2.6 Support services:

  *2.2.7 Innovation

***3. Market Sizing 

  **3.1 Market definition

  *Exhibit 11:  Offerings of vendors included in the market definition

  **3.2 Market size 2021 

  **3.3 Market segment analysis 

  *Exhibit 12:  Market segments

  **3.4 Market outlook: Forecast for 2021 - 2026 

  *Exhibit 13:  Global - Market size and forecast 2021 - 2026 ($ billion)

  *Exhibit 14:  Global market: Year-over-year growth 2021 - 2026 (%)

***4. Five Forces Analysis 

  **4.1 Five Forces Summary 

  *Exhibit 15:  Five forces analysis 2021 & 2026

  **4.2 Bargaining power of buyers 

  *Exhibit 16: Bargaining power of buyers

  **4.3 Bargaining power of suppliers 

  *Exhibit 17: Bargaining power of suppliers

  **4.4 Threat of new entrants 

  *Exhibit 18: Threat of new entrants

  **4.5 Threat of substitutes 

  *Exhibit 19: Threat of substitutes

  **4.6 Threat of rivalry 

  *Exhibit 20: Threat of rivalry

  **4.7 Market condition

  *Exhibit 21:  Market condition - Five forces 2021

***5 Market Segmentation by Route of administration 

  **5.1 Market segments

  *Exhibit 22:  Route of administration - Market share 2021-2026 (%)

  **5.2 Comparison by Route of administration 

  *Exhibit 23:  Comparison by Route of administration

  **5.3 Oral - Market size and forecast 2021-2026

  *Exhibit 24:  Oral - Market size and forecast 2021-2026 ($ billion)

  *Exhibit 25:  Oral - Year-over-year growth 2021-2026 (%)

  **5.4 Injectable - Market size and forecast 2021-2026 

  *Exhibit 26:  Injectable - Market size and forecast 2021-2026 ($ billion)

  *Exhibit 27:  Injectable - Year-over-year growth 2021-2026 (%)

  **5.5 Pulmonary - Market size and forecast 2021-2026 

  *Exhibit 28:  Pulmonary - Market size and forecast 2021-2026 ($ billion)

  *Exhibit 29:  Pulmonary - Year-over-year growth 2021-2026 (%)

  **5.6 Others - Market size and forecast 2021-2026 

  *Exhibit 30:  Others - Market size and forecast 2021-2026 ($ billion)

  *Exhibit 31:  Others - Year-over-year growth 2021-2026 (%)

  **5.7 Market opportunity by Route of administration 

  *Exhibit 32:  Market opportunity by Route of administration

***6. Customer landscape 

  **6.1 Overview

  *Technavio's customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria

  *Exhibit 33: Customer landscape

***7. Geographic Landscape 

  **7.1 Geographic segmentation

  *Exhibit 34:  Market share by geography 2021-2026 (%)

  **7.2 Geographic comparison 

  *Exhibit 35: Geographic comparison

  **7.3 North America - Market size and forecast 2021-2026 

  *Exhibit 36:  North America - Market size and forecast 2021-2026 ($ billion)

  *Exhibit 37:  North America - Year-over-year growth 2021-2026 (%)

  **7.4 Europe - Market size and forecast 2021-2026 

  *Exhibit 38:  Europe - Market size and forecast 2021-2026 ($ billion)

  *Exhibit 39:  Europe - Year-over-year growth 2021-2026 (%)

  **7.5 Asia - Market size and forecast 2021-2026

  *Exhibit 40:  Asia - Market size and forecast 2021-2026 ($ billion)

  *Exhibit 41:  Asia - Year-over-year growth 2021-2026 (%)

  **7.6 ROW - Market size and forecast 2021-2026 

  *Exhibit 42:  ROW - Market size and forecast 2021-2026 ($ billion)

  *Exhibit 43:  ROW - Year-over-year growth 2021-2026 (%)

  **7.7 Key leading countries 

  *Exhibit 44:  Key leading countries

  **7.8 Market opportunity by geography

  *Exhibit 45: Market opportunity by geography

***8. Drivers, Challenges, and Trends 

  **8.1 Market drivers 

  *8.1.1 Growing prevalence of chronic conditions

  *8.1.2 Increased strategic developments

  *8.1.3 Increase in regulatory approvals for drug delivery devices

  **8.2 Market challenges 

  *8.2.1 Product recalls can pose a challenge to manufacturers

  *8.2.2 Lack of trained professionals to administer drugs

  *8.2.3 Lack of proper healthcare infrastructure in developing countries

  *Exhibit 46:  Impact of drivers and challenges

  **8.3 Market trends 

  *8.3.1 Development of new drugs and vaccines for COVID-19

  *8.3.2 Rising adoption of self-injectable devices

  *8.3.3 Growing adoption of advanced drug delivery systems

***9. Vendor Landscape 

  **9.1 Competitive Scenario 

  **9.2 Overview

  *Exhibit 47: Vendor landscape

  *The potential for the disruption of the market landscape was moderate in 2020, and its threat is expected to remain unchanged by 2025. 

  **9.3 Landscape disruption 

  *Exhibit 48: Landscape disruption

  *Exhibit 49: Industry risks

***10. Vendor Analysis 

  **10.1 Vendors covered 

  *Exhibit 50: Vendors covered

  **10.2 Market positioning of vendors 

  *Exhibit 51: Market positioning of vendors

  *10.3 3M Co.

  *Exhibit 52:  3M Co. - Overview

  *Exhibit 53:  3M Co. - Business segments

  *Exhibit 54:  3M Co.- Key news

  *Exhibit 55:  3M Co. - Key offerings

  *Exhibit 56:  3M Co. - Segment focus

  **10.4 AbbVie Inc. 

  *Exhibit 57:  AbbVie Inc. - Overview

  *Exhibit 58:  AbbVie Inc. - Business segments

  *Exhibit 59:  AbbVie Inc. - Key offerings

  *Exhibit 60:  AbbVie Inc. - Segment focus

  **10.5 Antares Pharma Inc. 

  *Exhibit 61:  Antares Pharma Inc. - Overview

  *Exhibit 62:  Antares Pharma Inc. - Business segments

  *Exhibit 63:  Antares Pharma Inc. - Key offerings

  *Exhibit 64:  Antares Pharma Inc. - Segment focus

  **10.6 Becton Dickinson and Co. 

  *Exhibit 65:  Becton Dickinson and Co. - Overview

  *Exhibit 66:  Becton Dickinson and Co. - Business segments

  *Exhibit 67:  Becton Dickinson and Co. - Key offerings

  *Exhibit 68:  Becton Dickinson and Co. - Segment focus

  **10.7 BIOCORP Production 

  *Exhibit 69:  BIOCORP Production - Overview

  *Exhibit 70:  BIOCORP Production - Business segments

  *Exhibit 71:  BIOCORP Production - Key offerings

  *Exhibit 72:  BIOCORP Production - Segment focus

  *10.8 F. Hoffmann La Roche Ltd.

    *Exhibit 73:  F. Hoffmann La Roche Ltd. - Overview 

    *Exhibit 74:  F. Hoffmann La Roche Ltd. - Business segments 

    *Exhibit 75:  F. Hoffmann La Roche Ltd. - Key offerings 

    *Exhibit 76:  F. Hoffmann La Roche Ltd. - Segment focus 

  **10.9 Johnson and Johnson Inc.  

  *Exhibit 77:  Johnson and Johnson Inc.  - Overview

  *Exhibit 78:  Johnson and Johnson Inc.  - Business segments

  *Exhibit 79:  Johnson and Johnson Inc.  - Key offerings

  *Exhibit 80:  Johnson and Johnson Inc.  - Segment focus

  **10.10 Novartis AG 

  *Exhibit 81:  Novartis AG - Overview

  *Exhibit 82:  Novartis AG - Business segments

  *Exhibit 83:  Novartis AG.- Key news

  *Exhibit 84:  Novartis AG - Key offerings

  *Exhibit 85:  Novartis AG - Segment focus

  **10.11 Pfizer Inc. 

  *Exhibit 86:  Pfizer Inc. - Overview

  *Exhibit 87:  Pfizer Inc. - Business segments

  *Exhibit 88:  Pfizer Inc.- Key news

  *Exhibit 89:  Pfizer Inc. - Key offerings

  *Exhibit 90:  Pfizer Inc. - Segment focus

  **10.12 Teva Pharmaceutical Industries Ltd. 

  *Exhibit 91:  Teva Pharmaceutical Industries Ltd. - Overview

  *Exhibit 92:  Teva Pharmaceutical Industries Ltd. - Business segments

  *Exhibit 93:  Teva Pharmaceutical Industries Ltd. - Key offerings

  *Exhibit 94:  Teva Pharmaceutical Industries Ltd. - Segment focus

***11. Appendix 

  **11.1 Scope of the report 

  *11.1.1 Market definition

  *11.1.2 Objectives

  *11.1.3 Notes and Caveats

  **11.2 Currency conversion rates for US$ 

  *Exhibit 95: Currency conversion rates for US$

  **11.3 Research Methodology 

  *Exhibit 96: Research Methodology

  *Exhibit 97: Validation techniques employed for market sizing

  *Exhibit 98: Information sources

  **11.4 List of abbreviations 

  *Exhibit 99: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio